Sort
40,608 grants matching “prostate cancer”
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
$850,000Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2023 · AT
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
$850,000Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2022 · AT
DCP - COPTRG - SELECT/PCPT
$850,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Mouse Models of Prostate Cancer
$850,000Fred Hutchinson Cancer Research Center · U01 · FY2004 · CA
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
$850,000Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2021 · AT
A Mouse Model for Prostate Cancer
$849,196Univ Of Med/Dent Nj-R W Johnson Med Sch · U01 · FY2004 · CA
Novel Targets for Vaccine Therapy
$848,816Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Germline modifiers of tumor progression and metastasis
$848,726Nigel Crawford · National Human Genome Research Institute · ZIA · FY2010 · HG
Role of Neurotrophins in the Development of the Mammalian Nervous System
$848,710Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Signal Transduction Events and the Regulation of Cell Growth
$848,376Jane Neckers · Division Of Clinical Sciences - Nci · ZIC · FY2017 · CA
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
$848,325Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2018 · CA
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
$848,325Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2020 · CA
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
$848,325Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2016 · CA
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
$848,325Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2017 · CA
Center for Allaying Health Disparities Through Research and Education (CADRE)
$848,302Cynthia Jacksonhammond · Central State Univ (Wilberforce, Oh) · P20 · FY2012 · MD
SHCC MU NCORP
$847,814Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2016 · CA
Biomedical Image Analysis and Informatics
$847,611Matthew McAuliffe · Center For Information Technology · ZIA · FY2016 · CT
Vaccine and radiation for the therapy of human cancers
$847,016James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$847,016James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Signal Transduction Events and the Regulation of Cell Growth
$846,744Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$846,484James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Clinical trials employing cancer vaccine combination therapies
$846,484James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
CDK8/19 inhibitors for therapy of advanced prostate cancer
$846,340Mengqian Chen · Senex Biotechnology, Inc. · R44 · FY2021 · CA
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
$845,278Martin G Sanda · Beth Israel Deaconess Medical Center · U01 · FY2006 · CA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$845,000Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2021 · CA